Ligand Pharmaceuticals Inc (LGND)
110.05
+0.01
(+0.01%)
USD |
NASDAQ |
Nov 04, 16:00
110.05
0.00 (0.00%)
After-Hours: 16:02
Ligand Pharmaceuticals Net Income (Annual): 52.15M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 52.15M |
December 31, 2022 | -33.36M |
December 31, 2021 | 57.14M |
December 31, 2020 | -2.985M |
December 31, 2019 | 629.30M |
December 31, 2018 | 143.32M |
December 31, 2017 | 12.56M |
December 31, 2016 | -1.636M |
December 31, 2015 | 229.82M |
December 31, 2014 | 12.02M |
December 31, 2013 | 11.42M |
December 31, 2012 | -0.527M |
December 31, 2011 | 9.715M |
December 31, 2010 | -10.37M |
December 31, 2009 | -1.948M |
Date | Value |
---|---|
December 31, 2008 | -98.11M |
December 31, 2007 | 281.69M |
December 31, 2006 | -31.74M |
December 31, 2005 | -36.40M |
December 31, 2004 | -45.14M |
December 31, 2003 | -96.47M |
December 31, 2002 | -52.26M |
December 31, 2001 | -43.00M |
December 31, 2000 | -72.38M |
December 31, 1999 | -74.72M |
December 31, 1998 | -117.90M |
December 31, 1997 | -100.20M |
December 31, 1996 | -37.30M |
December 31, 1995 | -64.20M |
December 31, 1994 | -27.10M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-33.36M
Minimum
2022
629.30M
Maximum
2019
140.45M
Average
52.15M
Median
2023
Net Income (Annual) Benchmarks
Regeneron Pharmaceuticals Inc | 3.954B |
Agios Pharmaceuticals Inc | -352.09M |
ADMA Biologics Inc | -28.24M |
Pieris Pharmaceuticals Inc | -24.54M |
AnaptysBio Inc | -163.62M |